Live Cell Therapy as Potential Risk Factor for Q Fever
| dc.contributor.author | George, Maja | |
| dc.contributor.author | Reich, Andreas | |
| dc.contributor.author | Cussler, Klaus | |
| dc.contributor.author | Jehl, Herrmann | |
| dc.contributor.author | Burckhardt, Florian | |
| dc.date.accessioned | 2018-05-07T20:11:40Z | |
| dc.date.available | 2018-05-07T20:11:40Z | |
| dc.date.created | 2017-07-07 | |
| dc.date.issued | 2017-07-01 | none |
| dc.identifier.other | http://edoc.rki.de/oa/articles/reL0bA3aoQRkw/PDF/27rRmuOia6Xrs.pdf | |
| dc.identifier.uri | http://edoc.rki.de/176904/2696 | |
| dc.description.abstract | During an outbreak of Q fever in Germany, we identified an infected sheep flock from which animals were routinely used as a source for life cell therapy (LCT), the injection of fetal cells or cell extracts from sheep into humans. Q fever developed in 7 LCT recipients from Canada, Germany, and the United States. | eng |
| dc.language.iso | ger | |
| dc.publisher | Robert Koch-Institut | |
| dc.subject.ddc | 610 Medizin | |
| dc.title | Live Cell Therapy as Potential Risk Factor for Q Fever | |
| dc.type | periodicalPart | |
| dc.identifier.urn | urn:nbn:de:0257-10053281 | |
| dc.identifier.doi | http://dx.doi.org/10.25646/2621 | |
| local.edoc.container-title | Emerging Infectious Diseases | |
| local.edoc.fp-subtype | Artikel | |
| local.edoc.type-name | Zeitschriftenartikel | |
| local.edoc.container-type | periodical | |
| local.edoc.container-type-name | Zeitschrift | |
| local.edoc.container-url | https://wwwnc.cdc.gov/eid/article/23/7/16-1693_article | |
| local.edoc.container-publisher-name | Centers for Disease Control and Prevention | |
| local.edoc.container-volume | 23 | |
| local.edoc.container-issue | 7 | |
| local.edoc.container-year | 2017 |